Literature DB >> 25267889

Angiotensin receptor blockers for heart failure.

Phillip Jong1, Catherine Demers2, Robert S McKelvie3, Peter Liu4.   

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To determine the efficacy of ARBs on the survival of patients with heart failure when compared to placebo or ACEIs.To determine the efficacy of ARBs on hospitalization rates in patients with heart failure when compared to placebo or ACEIs.

Entities:  

Year:  2001        PMID: 25267889      PMCID: PMC4176658          DOI: 10.1002/14651858.CD003040

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  20 in total

1.  The hazards of scoring the quality of clinical trials for meta-analysis.

Authors:  P Jüni; A Witschi; R Bloch; M Egger
Journal:  JAMA       Date:  1999-09-15       Impact factor: 56.272

2.  Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart.

Authors:  H Urata; A Kinoshita; K S Misono; F M Bumpus; A Husain
Journal:  J Biol Chem       Date:  1990-12-25       Impact factor: 5.157

3.  Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.

Authors:  M D Flather; S Yusuf; L Køber; M Pfeffer; A Hall; G Murray; C Torp-Pedersen; S Ball; J Pogue; L Moyé; E Braunwald
Journal:  Lancet       Date:  2000-05-06       Impact factor: 79.321

Review 4.  Angiotensin II receptors.

Authors:  R Ardaillou
Journal:  J Am Soc Nephrol       Date:  1999-01       Impact factor: 10.121

5.  Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.

Authors:  Y H Liu; X P Yang; V G Sharov; O Nass; H N Sabbah; E Peterson; O A Carretero
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

6.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

7.  A general estimator for the variance of the Mantel-Haenszel odds ratio.

Authors:  J Robins; S Greenland; N E Breslow
Journal:  Am J Epidemiol       Date:  1986-11       Impact factor: 4.897

8.  Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.

Authors:  K Swedberg; P Eneroth; J Kjekshus; L Wilhelmsen
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

Review 9.  Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.

Authors:  E M Lonn; S Yusuf; P Jha; T J Montague; K K Teo; C R Benedict; B Pitt
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

10.  Determinants of angiotensin II generation during converting enzyme inhibition.

Authors:  L Juillerat; J Nussberger; J Ménard; V Mooser; Y Christen; B Waeber; P Graf; H R Brunner
Journal:  Hypertension       Date:  1990-11       Impact factor: 10.190

View more
  1 in total

Review 1.  Angiotensin receptor blockers for heart failure.

Authors:  Balraj S Heran; Vijaya M Musini; Ken Bassett; Rod S Taylor; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.